Advertisement

Topics

Precision medicine enabled histology agnostic development of immunotherapeutics

11:09 EDT 4 Jul 2017 | ecancermedicalscience

Prof Baynes speaks with ecancer at WIN 2017 about design and development of immune therapies sensitive to mutational deficiencies in the DNA repair pathway He notes the recent approval of pembrolizumab (Keytruda) PD1 therapy for relapsed cancer...

Original Article: Precision medicine enabled histology agnostic development of immunotherapeutics

NEXT ARTICLE

More From BioPortfolio on "Precision medicine enabled histology agnostic development of immunotherapeutics"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...